Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with back pain

By sjmartinez • November 7, 2024

Rodriguez A, Zeng C, Hays RD, Herman PM, Edelen MO. Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with back pain. Qual Life Res. 2024 Nov 6. doi: 10.1007/s11136-024-03826-6. Epub ahead of print. PMID: 39505759.

Tags: General Internal Medicine, health-related quality of life, patient-reported outcomes, PROMIS-16, PROMIS-29 + 2, Publications, Short form validation

The State of VA-funded Women Veterans’ Health Systems Research

Borsky AE, Kroll-Desrosiers A, Rodriguez A, Fenwick K, Friedman JK, Yano EM. The State of VA-funded Women Veterans' Health Systems Research. Womens Health Issues. 2025[...]

CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer

Huynh JT, Li R, Shin DS. CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer. J[...]

Clinical Telavancin Failure in Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia

Dao KT, D'Assumpcao C, Sharma R, Singh C, Kuran R, Heidari A. Clinical Telavancin Failure in Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia. Cureus. 2025 Feb 24;17(2):e79588.[...]